» Articles » PMID: 7776819

A Novel Electrophilic High Affinity Irreversible Probe for the Cannabinoid Receptor

Overview
Journal Life Sci
Publisher Elsevier
Date 1995 Jan 1
PMID 7776819
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

In order to explore the structural requirements for cannabinoid activity we have been involved in the design and synthesis of stereochemically defined high affinity probes for the cannabinoid receptor. This effort has involved the development of irreversible ligands which will allow us to obtain detailed information on the cannabinoid receptor active site(s). The irreversible ligands, which incorporate highly reactive functional groups in a strategic position of the ligand, may form covalent bonds with amino acid residues at the receptor active site or in the neighborhood of this site. We shall discuss the biochemical properties of one of these probes, which incorporates the electrophilic isothiocyanate group into the structure of the highly potent cannabinoid agonist (-)-1',1'-dimethylheptyl-delta 8-THC. This ligand, (-)-7'-isothiocyanato-1',1'-dimethylheptyl-delta 8-THC (7'-NCS-DMH-delta 8-THC), was evaluated for its affinity for cannabinoid binding sites using rat forebrain membrane preparations and found to have an apparent IC50 value of 660 pM. Incubation of the membrane preparation with a ligand concentration of five times the apparent IC50 resulted in the irreversible occupation of nearly all of the receptor specific binding sites.

Citing Articles

Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.

Alapafuja S, Malamas M, Shukla V, Zvonok A, Miller S, Daily L Bioorg Med Chem. 2018; 27(1):55-64.

PMID: 30446439 PMC: 8344409. DOI: 10.1016/j.bmc.2018.11.003.


2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.

Makriyannis A J Med Chem. 2014; 57(10):3891-911.

PMID: 24707904 PMC: 4064474. DOI: 10.1021/jm500220s.


Novel adamantyl cannabinoids as CB1 receptor probes.

Thakur G, Bajaj S, Paronis C, Peng Y, Bowman A, Barak L J Med Chem. 2013; 56(10):3904-21.

PMID: 23621789 PMC: 3706088. DOI: 10.1021/jm4000775.


Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition.

West J, Zvonok N, Whitten K, Vadivel S, Bowman A, Makriyannis A PLoS One. 2012; 7(8):e43877.

PMID: 22952796 PMC: 3432061. DOI: 10.1371/journal.pone.0043877.


A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents.

Cluny N, Vemuri V, Chambers A, Limebeer C, Bedard H, Wood J Br J Pharmacol. 2010; 161(3):629-42.

PMID: 20880401 PMC: 2990160. DOI: 10.1111/j.1476-5381.2010.00908.x.